Formosa Plastics Corporation, U.S.A. – Trademark Portfolio
Entity Type: 03
Formosa Plastics Corporation, U.S.A. owns a portfolio of 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as FORMOLON, FORMOLENE, FORMOSA PLASTICS, and YOU EXPECT MORE. AND FORMOSA DELIVERS.. Of these, 5 are registered and 6 are pending. The portfolio spans 4 Nice Classification classes, led by Class 1 (Chemicals) and Class 17 (Rubber Goods). Headquartered in Livingston, NJ.
9 Peach Tree Hill Road
Livingston, NJ 07039
Showing of trademarks Trademarks
Trademark Classifications
Formosa Plastics Corporation, U.S.A.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Formosa Plastics Corporation, U.S.A. have?
Formosa Plastics Corporation, U.S.A. has 22 U.S. trademarks filed with the USPTO. Of these, 5 registered, 6 pending, 7 abandoned, 4 cancelled.
What trademark classes does Formosa Plastics Corporation, U.S.A. file in?
Formosa Plastics Corporation, U.S.A. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 17 (Rubber Goods), Class 40 (Treatment & Processing), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Formosa Plastics Corporation, U.S.A.'s most well-known trademarks?
Formosa Plastics Corporation, U.S.A.'s registered trademark portfolio includes well-known marks such as FORMOLON, FORMOLENE, FORMOSA PLASTICS, and YOU EXPECT MORE. AND FORMOSA DELIVERS.. These are among 5 currently registered trademarks in the portfolio.
What is Formosa Plastics Corporation, U.S.A.'s trademark registration success rate?
Formosa Plastics Corporation, U.S.A. has a 31% trademark registration rate, with 5 out of 16 resolved applications resulting in successful registration. Currently, 6 applications are pending review.